ArticleJournal of gynecologic oncology2016
Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO).
Article in Journal of gynecologic oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.Journal of gynecologic oncology · 2018Guideline
- Uptake Rate of Risk-Reducing Salpingo-Oophorectomy and Surgical Outcomes of Female GermlineYonsei medical journal · 2021Article
- The Knowledge and Attitude of Patients Diagnosed with Epithelial Ovarian Cancer towards Genetic Testing.International journal of environmental research and public health · 2021Article
- Uptake of Family-Specific Mutation Genetic Testing Among Relatives of Patients with Ovarian Cancer with BRCA1 or BRCA2 Mutation.Cancer research and treatment · 2021Article
- Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea.Cancer research and treatment · 2020Article
- The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019: meeting report.Journal of gynecologic oncology · 2019Article
- Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer.Journal of ovarian research · 2019Article
- Asian Society of Gynecologic Oncology International Workshop 2018.Journal of gynecologic oncology · 2019Article
- Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999-2015.Journal of gynecologic oncology · 2019Article
- Bilateral salpingectomy to reduce the risk of ovarian/fallopian/peritoneal cancer in women at average risk: a position statement of the Korean Society of Obstetrics and Gynecology (KSOG).Obstetrics & gynecology science · 2018Review
- Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube.Journal of gynecologic oncology · 2018Article
- Germline and somatic mutations in homologous recombination genes among Chinese ovarian cancer patients detected using next-generation sequencing.Journal of gynecologic oncology · 2017Article
- Role and clinical application of next-generation sequencing (NGS) for ovarian cancer.Journal of gynecologic oncology · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.